Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Telba Irony

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|March 3, 2023
Bayesian Statistics for Medical Devices: Progress Since 2010Gregory Campbell, Telba Irony, Gene Pennello, et al.
Annals of Internal Medicine|September 20, 2021
U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013-2018Perrine Janiaud, Telba Irony, Estelle Russek-Cohen, et al.
Journal of Biopharmaceutical Statistics|March 11, 2017
Incorporation of stochastic engineering models as prior information in Bayesian medical device trialsTarek Haddad, Adam Himes, Laura Thompson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 26, 2020
Comparing clotting factors attributes across different methods of preference elicitation in haemophilia patientsMillion A Tegenge, Artur Belov, Megan Moncur, et al.
Drug Discovery Today|October 9, 2017
Patient-centered clinical trialsShomesh E Chaudhuri, Martin P Ho, Telba Irony, et al.
Learning Health Systems|June 28, 2019
Advancing the science of patient input throughout the regulatory decision-making processMillion A Tegenge, Megan M Moncur, Robert Sokolic, et al.
Therapeutic Innovation & Regulatory Science|April 15, 2023
Adaptation of the WOMAC for Use in a Patient Preference StudySarah Stothers Rosenberg, Xinyi Ng, Carol Mansfield, et al.
Journal of Biopharmaceutical Statistics|August 12, 2011
Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory settingPablo Bonangelino, Telba Irony, Shengde Liang, et al.
Nature Reviews. Drug Discovery|February 15, 2023
Application of Bayesian approaches in drug development: starting a virtuous cycleStephen J Ruberg, Francois Beckers, Rob Hemmings, et al.
Transplantation|June 3, 2022
Preferences for Risks and Benefits of Islet Cell Transplantation for Persons With Type 1 Diabetes With History of Episodes of Severe Hypoglycemia: A Discrete-Choice Experiment to Inform Regulatory DecisionsLeslie Wilson, Tiffany Kwok, Yanlei Ma, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|March 3, 2023
Bayesian Statistics for Medical Devices: Progress Since 2010Gregory Campbell, Telba Irony, Gene Pennello, et al.
Annals of Internal Medicine|September 20, 2021
U.S. Food and Drug Administration Reasoning in Approval Decisions When Efficacy Evidence Is Borderline, 2013-2018Perrine Janiaud, Telba Irony, Estelle Russek-Cohen, et al.
Journal of Biopharmaceutical Statistics|March 11, 2017
Incorporation of stochastic engineering models as prior information in Bayesian medical device trialsTarek Haddad, Adam Himes, Laura Thompson, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|August 26, 2020
Comparing clotting factors attributes across different methods of preference elicitation in haemophilia patientsMillion A Tegenge, Artur Belov, Megan Moncur, et al.
Drug Discovery Today|October 9, 2017
Patient-centered clinical trialsShomesh E Chaudhuri, Martin P Ho, Telba Irony, et al.
Learning Health Systems|June 28, 2019
Advancing the science of patient input throughout the regulatory decision-making processMillion A Tegenge, Megan M Moncur, Robert Sokolic, et al.
Therapeutic Innovation & Regulatory Science|April 15, 2023
Adaptation of the WOMAC for Use in a Patient Preference StudySarah Stothers Rosenberg, Xinyi Ng, Carol Mansfield, et al.
Journal of Biopharmaceutical Statistics|August 12, 2011
Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory settingPablo Bonangelino, Telba Irony, Shengde Liang, et al.
Nature Reviews. Drug Discovery|February 15, 2023
Application of Bayesian approaches in drug development: starting a virtuous cycleStephen J Ruberg, Francois Beckers, Rob Hemmings, et al.
Transplantation|June 3, 2022
Preferences for Risks and Benefits of Islet Cell Transplantation for Persons With Type 1 Diabetes With History of Episodes of Severe Hypoglycemia: A Discrete-Choice Experiment to Inform Regulatory DecisionsLeslie Wilson, Tiffany Kwok, Yanlei Ma, et al.
Pageof 2